Sarda Proteins Ltd Q3FY25 profit at Rs. 9.71 lakhs

has reported Standalone financial results for the period ended December 31, 2024.

Financial Results (Q3 FY2025) - QoQ Comparison

The company has reported total income of Rs. 24.0516 crores during the period ended December 31, 2024 as compared to Rs. 0.14 crores during the period ended September 30, 2024.

The company has posted net profit / (loss) of Rs. 0.0971 crores for the period ended December 31, 2024 as against net profit / (loss) of Rs. .1047 crores for the period ended September 30, 2024.

The company has reported EPS of Rs. 0.56 for the period ended December 31, 2024 as compared to Rs. 0.61 for the period ended September 30, 2024.

Financials	Q3 FY2025	Q2 FY2025	% Change
Total Income	₹24.0516 crs	₹0.14 crs	17,079.71%
Net Profit	₹0.0971 crs	₹.1047 crs	-7.26%
EPS	₹0.56	₹0.61	-8.20%

Financial Results (Q3 FY2025) - YoY Comparison

The company has reported total income of Rs.24.0516 crores during the period ended December 31, 2024 as compared to Rs.1.0420 crores during the period ended December 31, 2023.

The company has posted net profit / (loss) of Rs.0.0971 crores for the period ended December 31, 2024 as against net profit / (loss) of Rs.0.0069 crores for the period ended December 31, 2023.

The company has reported EPS of Rs.0.56 for the period ended December 31, 2024 as compared to Rs.0.04 for the period ended December 31, 2023.

Financials	Q3 FY2025	Q3 FY2024	% Change
Total Income	₹24.0516 crs	₹1.0420 crs	2,208.21%
Net Profit	₹0.0971 crs	₹0.0069 crs	1,307.25%
EPS	₹0.56	₹0.04	1,300.00%

Financial Results (9 Months Ended FY2025) - YoY Comparison

The company has reported total income of Rs.24.1916 crores during the 9 Months period ended December 31, 2024 as compared to Rs.1.36 crores during the 9 Months period ended December 31, 2023.

The company has posted net profit / (loss) of Rs.0.1217 crores for the 9 Months period ended December 31, 2024 as against net profit / (loss) of Rs.-0.0007 crores for the 9 Months period ended December 31, 2023.

The company has reported EPS of Rs.0.71 for the 9 Months period ended December 31, 2024 as compared to Rs.-0.004 for the 9 Months period ended December 31, 2023.

Financials	9 Months Ended FY2025	9 Months Ended FY2024	% Change
Total Income	₹24.1916 crs	₹1.36 crs	1,678.79%
Net Profit	₹0.1217 crs	₹-0.0007 crs	17,485.71%
EPS	₹0.71	₹-0.004	17,850.00%

Source : Equity Bulls

Keywords

SardaProteins Q3FY25 9MFY25 Q3FY2025 9MFY2025 ResultUpdate